Comparison of RAMP & VecTests for WNV

USCDC and Health Canada present RAMP WNV evaluation at the AMCA
meeting, 21-25th Feb 2004.

To see full paper, visit <http://www.responsebio.com>www.responsebio.com

Product Manager - Vector Surveillance
Response Biomedical
8081 Lougheed Highway
Burnaby,B.C.
Canada V5A1W9

Tel: 1-888 591 5577 ext 230
        604 681 4101 ext 230
E-Mail <mailto:cmallison@responsebio.com>cmallison@responsebio.com

[Information added by WNV-L moderator:
Title: "Evaluation of Commercial Assays for Detecting West Nile Virus Antigen."
Authors: K.L. Burkhalter, R. Lindsay, R. Anderson, A. Dibernardo, H.
White, M. Drebot, W. Fong, R. Nasci
Introduction: "The CDC and Health Canada laboratories collaborated in
an effort to test the sensitivity and specificity of the
commercially-available Response Biomedical RAMP West Nile Virus
(WNV) detection assay and compare it to the sensitivity of the
VecTest WNV assay from Medical Analysis Systems (MAS)."]

--
-------------------------------------------------------------------------------------------
WESTNILEVIRUS-L is an email discussion group for communication
and discussion about West Nile Virus, particularly regarding policy,
risk reduction and public education issues. It is moderated by
Dr. Lois Levitan, Program Leader of the Cornell University
Environmental Risk Analysis Program (ERAP).  Archives are posted at:
<environmentalrisk.cornell.edu/WNV/WNV-L_ArchiveIndex.html>
To subscribe (or unsubscribe), send an email request with your name
and contact information to <envrisk@cornell.edu>.
To receive messages once a day in digest format,  subscribers can
send an email to <listproc@cornell.edu> with message:
"set WESTNILEVIRUS-L mail digest-nomime".
Subscribers are encouraged to post to the group by sending
messages to <envrisk@cornell.edu>.  Please put "WNV Listserv" in
the subject line and send only unformatted text, without attachments.
---------------------------------------------------------------------------------------------